Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art

SIMPLE SUMMARY: The treatment of aggressive and metastatic pituitary neuroendocrine tumors (PitNETs) refractory to current therapies, including temozolomide, is challenging and hopes are relying on personalized therapies. Immunotherapy based on immune checkpoint inhibitors (ICIs) is a revolutionary...

Descripción completa

Detalles Bibliográficos
Autores principales: Feola, Tiziana, Carbonara, Francesca, Verrico, Monica, Di Crescenzo, Rosa Maria, Gianno, Francesca, Colonnese, Claudio, Arcella, Antonietta, de Alcubierre, Dario, Tomao, Silverio, Esposito, Vincenzo, Giangaspero, Felice, Minniti, Giuseppe, Jaffrain-Rea, Marie-Lise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454884/
https://www.ncbi.nlm.nih.gov/pubmed/36077631
http://dx.doi.org/10.3390/cancers14174093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454884/
https://www.ncbi.nlm.nih.gov/pubmed/36077631
http://dx.doi.org/10.3390/cancers14174093

Ejemplares similares